Latest News
Connect Biopharma: Attempting To Differentiate Rademikibart From Dupixent
CNTB is developing rademikibart, a drug with a similar mechanism of action to SNY/REGN's blockbuster Dupixent. The company is approaching a readout from two trials, Seabreeze STAT Asthma and Seabreeze
ServiceNow bets $40 million on Indian banking software specialist to expand its financial services push
ServiceNow, the U.S. enterprise software company known for automating workflows like IT service management and HR operations, is betting on an Indian banking software specialist to deepen its push int
Constellation Brands Shareholders Approve Directors, Pay and Incentive Plan at Annual Meeting
Constellation Brands NYSE: STZ held its 2026 annual meeting of stockholders on July 22, with shareholders approving all items presented for a vote, according to preliminary results announced during th
Fermi Inc. Admission of shares of Common Stock and Total Voting Rights
DALLAS, July 23, 2026 /PRNewswire/ -- Fermi Inc. (NASDAQ and LSE: FRMI) (LEI: 529900TSHBYBCFMYZ228), ("Fermi" or the "Company"), the Texas-based company focused on developing electric grids that deliv
Venus Medtech annonce la fin du recrutement des patients dans le cadre de l'essai clinique décisif mené en Chine sur le Venus-PowerX, le premier système TAVR au monde à valve sèche auto-expansible et entièrement récupérable
/PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (02500.HK) a annoncé aujourd'hui que le recrutement des patients était terminé dans le cadre de son essai
Venus Medtech Announces Completion of Patient Enrollment in Pivotal China Trial for Venus-PowerX, the World's First Fully Recoverable Self-Expanding Dry-Valve TAVR System
/PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (02500.HK) today announced that patient enrollment has been completed in its confirmatory clinical trial for the
Venus Medtech anuncia la finalización del reclutamiento de pacientes para el ensayo clínico de Venus-PowerX
/PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (02500.HK) anunció hoy la finalización del reclutamiento de pacientes para el ensayo clínico confirmatorio del
AMD: The Full-Stack AI Opportunity
AMD (AMD) remains a compelling buy, with a new base case price target of $671 (21% upside) and a bullish scenario at $807.87 (45% upside). AMD's flexible, customizable AI infrastructure—spanning GPUs,
Progress Software Corporation (PRGS) M&A Call Transcript
Progress Software Corporation (PRGS) M&A Call Transcript
Teck Reports Unaudited Second Quarter Results for 2026
VANCOUVER, British Columbia, July 23, 2026 (GLOBE NEWSWIRE) -- Teck Resources Limited (TSX: TECK. A and TECK. B, NYSE: TECK) (Teck) today announced its unaudited second quarter results for 2026. "We d
TGS Quarterly Dividend
OSLO, NORWAY (23 July 2026) - Following the authorization from the Annual General Meeting on 29 April 2026, the Board of TGS ASA has resolved to distribute a quarterly dividend of the NOK equivalent o
Teck Reports Unaudited Second Quarter Results for 2026
Strong second quarter earnings driven by operational consistency and disciplined execution Strong second quarter earnings driven by operational consistency and disciplined execution
CSX Corporation (CSX) Q2 2026 Earnings Call Transcript
CSX Corporation (CSX) Q2 2026 Earnings Call Transcript
Silver and gold prices stage a cautious rebound — but analysts see slim hopes for a sustained rally
Spot gold and silver prices have rallied this week, but remain well below all-time highs achieved in late January. Analysts attribute recent gains to "bargain hunting" but see little chance of a susta
Medidata Launches Medidata Plus, an AI-Native Foundation Built to Scale Clinical Portfolios
NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions, today announced the launch of Medidata Plus. This clinical artificial
Start of Day Message
LONDON, 23 Jul. 2026 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information provi
Renault Group prioritizes electrification of its vehicle lineup and sales quality
PRESS RELEASEJuly 23, 2026 RENAULT GROUP PRIORITIZES ELECTRIFICATION OF ITS VEHICLE LINEUP AND SALES QUALITY In 2026 H1, Renault Group recorded stable global sales, with 1,165,133 vehicles sold (-0. 4
TGS announces Q2 2026 results
OSLO, Norway (23 July 2026) - TGS today reports interim financial results for Q2 2026. Financial highlights: Revenues of USD 400 million driven by high multi-client activity and strong sales in North
Gestage groei van de EBITDAaL dankzij goed stand houdende omzet, waardemanagement en voortgezette efficiëntiewinsten
Financiële informatie voor het eerste halfjaar van 2026 Gestage groei van de EBITDAaL dankzij goed stand houdende omzet, waardemanagement en voortgezette efficiëntiewinsten Aantal mobiele postpaidklan
[Ad-hoc-Mitteilung gemäss Art. 53 KR] Roche setzt starke Dynamik in erstem Halbjahr 2026 mit Umsatzwachstum von +6% zu konstanten Wechselkursen fort; -2% in CHF aufgrund deutlicher Aufwertung des Schweizer Frankens
Konzernverkäufe stiegen in den ersten sechs Monaten um6% zu konstanten Wechselkursen (CER1; in CHF ausgewiesen -2% und auf USD-Basis28%) aufgrund hoher Nachfrage nach innovativen Medikamenten und Diag